Once free, drug for rare disease now being sold for $375K a year
02:01
Thanks to a law designed to encourage drug development for rare diseases, Catalyst Pharmaceuticals can now sell the treatment exclusively for seven years -- and has set the price for it at $375,000 on average, when it used to be given to patients for free by a smaller drug company.Feb. 7, 2019
UP NEXT
Uvalde community takes action in grief
01:29
Ray Liotta passes away at 67 years old
01:29
Carnival Freedom cruise ship catches on fire
01:13
Senators in Washington see a chance for new gun legislation
02:03
Students and parents remember the day of the Uvalde, Texas massacre
05:07
Police face questions on Texas elementary school shooting timeline